Bio-Techne Corp. diskutieren
Bio-Techne Corp.
WKN: A12ENG / Symbol: TECH / Name: Bio-Techne / Aktie / Ausrüstung & Versorgung / Mid Cap /
49,80 €
0,40 %
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $120.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at KeyCorp from $115.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Citigroup Inc. from $100.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stifel Nicolaus from $104.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $80.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stephens from $92.00 to $87.00. They now have an "overweight" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $73.00 to $81.00. They now have an "outperform" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at KeyCorp from $80.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $75.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Benchmark Co. from $95.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $59.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $75.00 price target on the stock.
Ratings data for TECH provided by MarketBeat
Neueste Beiträge
Stifel_Nicolaus in C.H. Robinson Worldwide Inc. diskutieren